April 20 (Reuters) - Biosyent Inc RX.V :
* Biosyent extends in-license agreement for cathejell(r)
* Biosyent Inc - extended its license, distribution and supply agreement with its European partner, Pharmazeutische Fabrik Montavit GES.M.B.H.
* Extensio gives Biosyent Pharma exclusive Canadian rights to cathejell jelly 2 pct product until march 31, 2024 Source text for Eikon: ID:nCCN5VWHPr Further company coverage: RX.V